Quince Therapeutics, Inc. Gains 86.29%
Tue, Apr 07, 2026 at 07:22 PM
Quince Therapeutics, Inc. (QNCX:NASDAQ) soared at $0.16, a gain of 86.3%. On Tue, Apr 07, 2026, QNCX:NASDAQ touched a New 2-Week High of $0.16. The stock appeared on our News Catalysts scanner on Fri, Apr 03, 2026 at 03:10 AM in the 'EARNINGS' category. From Tue, Mar 24, 2026, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Tue, Jan 20, 2026 at $3.72 with a volume of 1M+.
About Quince Therapeutics, Inc. (QNCX:NASDAQ)
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 2900%
- Xiao-I Corporation (AIXI:NASDAQ), 142.6%
- Huachen AI Parking Management Technology Holding Co., Ltd (HCAI:NASDAQ), 142.33%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 86.29%
- Heritage Distilling Holding Co. Inc. (IPST:NASDAQ), 65.22%
- Cemtrex, Inc. (CETX:NASDAQ), 62.41%
- Movano Inc. (MOVE:NASDAQ), 59.31%
- HUB Cyber Security Ltd. (HUBC:NASDAQ), 55.41%
- LanzaTech Global, Inc. (LNZA:NASDAQ), 52.51%